NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.
With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
Texans rank pharmacies as most accessible healthcare destination tested, and support policies that would continue to allow patient choice when it comes to accessing services.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
NACDS engages in White House Conference with commitments and recommendations, hosts “satellite event” to extend reach of event.
One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
